-+ 0.00%
-+ 0.00%
-+ 0.00%
NextCell Pharma Presents Cell Therapy Manufacturing Strategy at BIO-Europe
Share
Listen to the news
NextCell Pharma Presents Cell Therapy Manufacturing Strategy at BIO-Europe
  • NextCell Pharma will attend BIO-Europe 2026 in Cologne, Germany, November 9-11.
  • Chief Scientific Officer Lindsay Davies will present November 10 on moving allogeneic cell therapies from clinical development to commercial production.
  • Her presentation will draw on manufacturing experience from the NXTCL cell therapy platform.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCell Pharma AB published the original content used to generate this news brief via Cision (Ref. ID: 202611090700BITN____UKPR__EN_20261109-BIT-6694-0) on November 09, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending